Improving detection of clinically significant prostate cancer: Magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy

Journal of Urology

Volumn 191, Issue 6, 2014, Pages 1749-1754

  Rastinehad, Ardeshir R ^a,b   Turkbey, Baris ^a,b   Salami, Simpa S ^a,b   Yaskiv, Oksana ^a,b   George, Arvin K ^a,b   Fakhoury, Mathew ^a,b   Beecher, Karin ^a,b   Vira, Manish A ^a,b   Kavoussi, Louis R ^a,b   Siegel, David N ^a,b   Villani, Robert ^a,b   Ben Levi, Eran ^a,b  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

biopsy; magnetic resonance imaging; prostate; prostatic neoplasms; ultrasonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CANCER SIZE; DIAGNOSTIC IMAGING; EXTERNAL VALIDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY; ULTRASOUND SCANNER; AREA UNDER THE CURVE; CANCER SCREENING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GLEASON SCORE; INTERMETHOD COMPARISON; LIKERT SCALE; MAGNETIC RESONANCE IMAGING-ULTRASOUND FUSION-GUIDED PROSTATE BIOPSY DEVICE; NATIONAL HEALTH ORGANIZATION; SCORING SYSTEM; TRANSRECTAL ULTRASOUND FUSION GUIDED PROSTATE BIOPSY; TUMOR VOLUME; VERY ELDERLY; CANCER GRADING; CLINICAL TRIAL; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; IMAGE GUIDED BIOPSY; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; LARGE CORE NEEDLE BIOPSY; MIDDLE AGED; PROCEDURES; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; RETROSPECTIVE STUDY; STANDARDS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, LARGE-CORE NEEDLE; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMAGE-GUIDED BIOPSY; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84900386628     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.12.007     Document Type: Article

References (20)

1. P.F. Pinsky, A. Black, and H.L. Parnes Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial Cancer Epidemiol 36 2012 e401
2. F.H. Schröder, J. Hugosson, and M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320
3. U.S. Preventive Services Task Force: Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement. Release Date: May 2012. Rockville, Maryland: United States Preventive Services Task Force 2012.
4. B. Turkbey, H. Mani, and V. Shah Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds J Urol 186 2011 1818
5. J. Haffner, L. Lemaitre, and P. Puech Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection BJU Int 108 2011 E171
6. P.A. Pinto, P.H. Chung, and A.R. Rastinehad Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging J Urol 186 2011 1281
7. Turkbey B, Merino MJ and Gallardo EC: Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology. J Magn Reson Imaging 2013. Epub ahead of print.
8. J.O. Barentsz, J. Richenberg, and R. Clements et al. ESUR prostate MR guidelines 2012. European Society of Urogenital Radiology Eur Radiol 22 2012 746
9. A.R. Rastinehad, A.A. Baccala Jr., and P.H. Chung D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging J Urol 185 2011 815
10. J.I. Epstein, P.C. Walsh, and M. Carmichael Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368
11. H.U. Ahmed, Y. Hu, and T. Carter Characterizing clinically significant prostate cancer using template prostate mapping biopsy J Urol 186 2011 458
12. F.H. Schröder, J. Hugosson, and M.J. Roobol Prostate-cancer mortality at 11 years of follow-up. ERSPC Investigators N Engl J Med 366 2012 981
13. M.M. Siddiqui, S. Rais-Bahrami, and H. Truong et al. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy Eur Urol 64 2013 713
14. C.M. Moore, N.L. Robertson, and N. Arsanious Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review Eur Urol 63 2013 125
15. M.C. Gittelman, B. Hertzman, and J. Bailen PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study J Urol 190 2013 64
16. G.D. Stewart, L. Van Neste, and P. Delvenne Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study J Urol 189 2013 1110
17. B. Turkbey, H. Mani, and O. Aras Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology 268 2013 144
18. L. Stamatakis, M.M. Siddiqui, and J.W. Nix Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer Cancer 119 2013 3359
19. E. Lecornet, H.U. Ahmed, and Y. Hu The accuracy of different biopsy strategies for the detection of clinically important prostate cancer: a computer simulation J Urol 188 2012 974
20. M. Abd-Alazeez, A. Kirkham, and H.U. Ahmed Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard Prostate Cancer Prostatic Dis 17 2014 40